The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Compliance for Peptide Therapy and BPC 157 Holt Law Compounded "semaglutide" is not FDA approved semaglutide.com Columbia Undergraduate Science Journal BPC 157: Miracle Healing Peptide or Hidden Danger? The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and